Drugs Made In America Acquisition II Corp. (DMIIR) › Operating IncomeDrugs Made In America Acquisition II Corp. (DMIIR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.Fiscal YearOperating IncomeChange YoY2025-$488.4K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share